Animal models of inflammatory and obstructive lung diseases, lung mucosal immunology, mucin biology.
BS Cum Laude: University of Milan, 1996; PhD: University of Milan, 2001; Postdoctoral Research Associate: University of North Carolina at Chapel Hill, Cystic Fibrosis Research and Treatment Center, 2002- 2005; Research Associate: University of North Carolina at Chapel Hill, Cystic Fibrosis Research and Treatment Center, 2005-2013; Research Assistant Professor of Medicine: University of North Carolina at Chapel Hill, Marsico Lung Institute/Cystic Fibrosis Center, 2014-2020; Research Associate Professor of Medicine, University of North Carolina at Chapel Hill, Marsico Lung Institute/Cystic Fibrosis Center, 2021-present
Our research focuses on understanding the molecular mechanisms involved in the derangement of mucus clearance and how its impairment impact other components of the airway mucosal immune system. Over the years, I have a developed a keen interest in using mouse models as a tool to understand the pathogenesis of obstructive lung disease, identify unique targets and test novel therapeutic approaches for translational research. In our lab, these studies nicely complement studies performed in available human specimens or simplified in vitro systems (e.g., primary cultures of airway epithelial cells differentiated at the air-liquid interface). Current research activities in the lab cover three main areas:
- Mouse models of defective airway mucus clearance are used to study responses to environmental and infectious challenges, to develop models of chronic airway infections, and to test efficiency and pharmacokinetic properties of mucokinetic/mucolytic/gene-editing therapies.
- Genetically engineered mouse models are used to study the contribution of specific components of the airway mucus clearance system (mucins secretion and assembly, ion, transport, cilia) in determining measurable phenotypes in both naïve and experimentally challenged conditions.
- Germ-free and specific pathogen-free mice are used to study the influence of age and host microbiota in the composition and function of airway mucus. These studies, funded by a recently awarded NHLBI R01, are complemented by efforts to define the pediatric airway epithelial landscape in healthy humans.
My very own background, along with the experience accumulated in 20 years of “American life”, had made me very keen in pursuing and practice diversity, equity, and inclusion inside and outside the workplace.
Marsico Lung Institute/Cystic Fibrosis Center
Department of Microbiology and Immunology
- Livraghi-Butrico A, Franklin TB, Wolfgang MC. The rat takes the cheese: a novel model of CFTR-dependent chronic bacterial airway infection. Editorial. Eur Resp J. 2022 Sep 7;60(3):2200832. doi: 10.1183/13993003.00832-2022.
- Kim N, Kwak G, Rodriguez J, Livraghi-Butrico A, Zuo X, Simon V, Han E, Shenoy SK, Pandey N, Mazur M, Birket SE, Kim A, Rowe SM, Boucher R, Hanes J, Suk JS. Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier. Thorax. 2022 Aug;77(8):812-820. doi: 10.1136/thoraxjnl-2020-215185. PMID: 34697091. PMCID: PMC9129924.
- Grubb BR, Livraghi-Butrico A. Animal models of cystic fibrosis in the era of highly effective modulator therapies. Review. Curr Opin Pharmacol. 2022 Jun;64:102235. doi: 10.1016/j.coph.2022.102235.PMID: 35576754; PMCID: PMC9386876.
- Rogers TD, Button B, Kelada SNP, Ostrowski LE, Livraghi-Butrico A, Gutay MI, Esther CR Jr, Grubb BR. Regional Differences in Mucociliary Clearance in the Upper and Lower Airways. Front Physiol. 2022 Mar 9;13:842592. doi: 10.3389/fphys.2022.842592. PMID: 35356083; PMCID: PMC8959816.
- Xu J, Livraghi-Butrico A, Hou X, Rajagopalan C, Zhang J, Song J, Jiang H, Wei HG, Wang H, Bouhamdan M, Ruan J, Yang D, Qiu Y, Xie Y, Barrett R, McClellan S, Mou H, Wu Q, Chen X, Rogers TD, Wilkinson KJ, Gilmore RC, Esther CR Jr, Zaman K, Liang X, Sobolic M, Hazlett L, Zhang K, Frizzell RA, Gentzsch M, O’Neal WK, Grubb BR, Chen YE, Boucher RC, Sun F. Phenotypes of CF rabbits generated by CRISPR/Cas9-mediated disruption of the CFTR gene. JCI Insight. 2021 Jan 11;6(1):e139813. doi: 10.1172/jci.insight.139813. PMID: 33232302. PMCID: PMC7821608.
- Ehre C, Rushton ZL, Wang B, Hothem LN, Morrison CB, Fontana NC, Markovetz MR, Delion MF, Kato T, Villalon D, Thelin WR, Esther CR Jr, Hill DB, Grubb BR, Livraghi-Butrico A, Donaldson SH, Boucher RC. An Improved Inhaled Mucolytic to Treat Airway Muco-Obstructive Diseases. Am J Respir Crit Care Med. 2019 Jan 15;199(2):171-180. doi: 10.1164/rccm.201802-0245OC. PMID: 30212240. PMCID: PMC6353008.
- Chen G, Volmer AS, Wilkinson KJ, Deng Y, Jones LC, Yu D, Bustamante-Marin XM, Burns KA, Grubb BR, O’Neal WK, Livraghi-Butrico A, Boucher RC. Role of Spdef in the regulation of Muc5b expression in the airways of naïve and muco-obstructed mice. Am J Respir Cell Mol Biol. 2018 Sep;59(3):383-396. PMID: 29579396. PMCID: PMC6189647.
- Livraghi-Butrico A, Wilkinson KJ, Volmer AS, Gilmore RC, Rogers TD, Caldwell RA, Burns KA, Esther CR Jr, Mall MA, Boucher RC, O’Neal WK, Grubb BR. Lung disease phenotypes caused by over-expression of combinations of alpha, beta, and gamma subunits of the epithelial sodium channel in mouse airways. Am J Physiol Lung Cell Mol Physiol 2018 Feb 1;314(2):L318-L331. PMID: 29074490. PMCID: PMC5866504.
- Donoghue LJ, Livraghi-Butrico A, McFadden KM, Thomas JM, Chen G, Grubb BR, O’Neal WK, Boucher RC, Kelada SNP. Identification of trans protein QTL for secreted airway mucins in mice and a causal role for Bpifb1. Genetics 2017 Oct;207(2):801-812. PMID: 28851744. PMCID: PMC5629340.
- Livraghi-Butrico A, Grubb BR, Wilkinson KJ, Volmer AS, Burns KA, Evans CM, O’Neal WK, Boucher RC. Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease. Mucosal Immunol 2017;10(2):395-407. PMID: 27435107. PMCID: PMC5250616.
- Grubb BR, Livraghi-Butrico A, Rogers TD, Yin W, Button B, Ostrowski LE. Reduced mucociliary clearance in old mice is associated with a decrease in Muc5B mucin. Am J Physiol Lung Physiol 2016 May 1;310(9):L860-7. PMID: 26968767. PMCID: PMC4867354.
- Roy MG*, Livraghi-Butrico A*, Fletcher AA*, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, Tuvim MJ, Adachi R, Romo I, Bordt AS, Bowden MG, Sisson JH, Woodruff PG, Thornton DJ, Rousseau K, De la Garza MM, Moghaddam SJ, Karmouty-Quintana H, Blackburn MR, Drouin SM, Davis CW, Terrell KA, Grubb BR, O’Neal WK, Flores SC, Cota-Gomez A, Lozupone CA, Donnelly JM, Watson AM, Hennessy CE, Keith RC, Yang IV, Barthel L, Henson PM, Janssen WJ, Schwartz DA, Boucher RC, Dickey BF, Evans CM. Muc5b is required for airway defense. Nature 2014 Jan 16;505(7483):412-6. PMID: 24317696. PMCID: PMC4001806.
- Livraghi-Butrico A, Kelly EJ, Wilkinson KJ, Rogers TD, Gilmore RC, Harkema JR, Randell SH, Boucher RC, O’Neal WK, Grubb BR. Loss of Cftr function exacerbates the phenotype of Na+ hyperabsorption in murine airways. Am J Physiol Lung Cell Mol Physiol 2013 Apr 1;304(7):L469-80. PMID: 23377346. PMCID: PMC3627939.
- Livraghi-Butrico A, Kelly EJ, Klem ER, Dang H, Wolfgang MC, Boucher RC, Randell SH, O’Neal WK. Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation. Mucosal Immunol 2012 Jul 5(4):397-408. PMID: 22419116. PMCID: PMC3377774.
- Livraghi-Butrico A, Grubb BR, Kelly EJ, Wilkinson KJ, Yang H, Geiser M, Randell SH, Boucher RC, O’Neal WK. Genetically determined heterogeneity of lung disease in a mouse model of airway mucus obstruction. Physiol Genomics 2012 Apr 15;44(8):470-84. PMID: 22395316. PMCID: PMC3339860.
- Livraghi A, Mall M, Paradiso AM, Boucher RC, Ribeiro CM. Modeling dysregulated Na+ absorption in airway epithelial cells with mucosal nystatin treatment. Am J Respir Cell Mol Biol 2008 Apr;38(4):423-34. PMID: 17989361. PMCID: PMC2274946.
Complete List of Published Work in MyBibliography: